Patent ID: 8288430

Claim:
A compound of the formula (1): wherein A 1 stands for â€”CR 7 â•, A 2 stands for â€”CR 8 â•, A 3 stands for â€”CR 9 â•, A 4 stands for â€”CR 10 â•; Y 1 , Y 1 â€², Y 2 , Y 2 â€², Y 3 , Y 3 â€², Y 4 and Y 4 â€² are selected respectively independently of one another from the group consisting of â€”H, â€”F, â€”Cl, â€”Br, â€”R 0 , â€”SH, â€”SR 0 , â€”S(â•O) 1-2 â€”R 0 , â€”NH 2 , â€”NHR 0 , and â€”N(R 0 ) 2 ; W stands for â€”NR 4 â€”; R 0 respectively independently stands for â€”C 1-8 -aliphatic, -aryl, or â€”C 1-8 -aliphatic-aryl; R 1 and R 2 , independently of one another, stand for â€”H or â€”R 0 ; or R 1 and R 2 together stand for â€”CH 2 CH 2 OCH 2 CH 2 â€”, â€”CH 2 CH 2 NR 11 CH 2 CH 2 â€” or â€”(CH 2 ) 3-6 â€”; R 3 stands for â€”R 0 or 2-thienyl; R 4 stands for â€”H or â€”R 0 ; R 5 , R 5 â€², R 6 , R 6 â€², R 7 , R 8 , R 9 , R 10 , R 18 and R 19 respectively independently of one another stand for â€”H, â€”F, â€”Cl, â€”Br, â€”SR 13 , â€”S(â•O) 2 R 13 , â€”C(â•O)OR 13 , â€”C(â•O)NR 13 , â€”C(â•O)NR 0 OR 0 , â€”NR 14 R 15 , â€”NHC(â•O)R 0 , CH 2 OH or â€”R 0 ; R 13 respectively independently stands for â€”H or â€”R 0 ; R 14 and R 15 independently of one another stand for â€”H or â€”R 0 ; wherein â€œaliphaticâ€ respectively is a branched or unbranched, saturated or a mono- or polyunsaturated, unsubstituted or mono- or polysubstituted, aliphatic hydrocarbon residue; wherein with respect to â€œaliphaticâ€, â€œmono- or polysubstitutedâ€ means the mono- or polysubstitution of one or more hydrogen atoms by â€”F, â€”Cl, â€”Br, or â€”R 0 ; â€œarylâ€, respectively independently, stands for a carbocyclic ring system with at least one aromatic ring, but without heteroatoms in this ring, wherein, if necessary, the aryl residues can be condensed with further saturated, (partially) unsaturated or aromatic ring systems, and each aryl residue can be present in unsubstituted or mono- or polysubstituted form, wherein the aryl substituents can be the same or different and in any desired and possible position of the aryl and are selected from the group consisting of â€”F, â€”Cl, â€”Br, and â€”R 0 ; said compound being in the form of a single stereoisomer or mixture thereof, the free compound and/or a physiologically compatible salt thereof.